Further observations on the interaction of prostaglandin F2 alpha with cholinergic mechanisms in canine salivary glands.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002814:Chorda Tympani Nerve / Q000187:drug effects / Q000502:physiology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D006863:Hydrogen-Ion Concentration; D007536:Isomerism; D009474:Neurons / Q000187:drug effects; D010275:Parasympathetic Nervous System / Q000187:drug effects*; D011188:Potassium / Q000032:analysis; D011453:Prostaglandins / Q000494:pharmacology*; D011506:Proteins / Q000032:analysis; D012039:Regional Blood Flow; D012463:Saliva / Q000032:analysis; D012472:Salivation / Q000187:drug effects*; D012636:Secretory Rate; D012964:Sodium / Q000032:analysis; D013363:Submandibular Gland / Q000294:innervation* / Q000378:metabolism; D013779:Tetrodotoxin / Q000032:analysis / Q000494:pharmacology
D011453:Prostaglandins; D011506:Proteins; D013779:Tetrodotoxin; D001285:Atropine; D012964:Sodium; D000109:Acetylcholine; D011188:Potassium